O-GlcNAcylation in health and neurodegenerative diseases

BE Lee, PG Suh, JI Kim - Experimental & Molecular Medicine, 2021 - nature.com
O-GlcNAcylation is a posttranslational modification that adds O-linked β-N-
acetylglucosamine (O-GlcNAc) to serine or threonine residues of many proteins. This protein …

The two-century journey of Parkinson disease research

S Przedborski - Nature Reviews Neuroscience, 2017 - nature.com
Since the first formal description of Parkinson disease (PD) two centuries ago, our
understanding of this common neurodegenerative disorder has expanded at all levels of …

[HTML][HTML] Parkinson's disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis

G DeMaagd, A Philip - Pharmacy and therapeutics, 2015 - ncbi.nlm.nih.gov
Parkinson’s Disease and Its Management - PMC Back to Top Skip to main content NIH NLM
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search …

Cross-frequency coupling and intelligent neuromodulation

CH Yeh, C Zhang, W Shi, MT Lo… - Cyborg and bionic …, 2023 - spj.science.org
Cross-frequency coupling (CFC) reflects (nonlinear) interactions between signals of different
frequencies. Evidence from both patient and healthy participant studies suggests that CFC …

Intranasal nanoemulsions for direct nose-to-brain delivery of actives for CNS disorders

S Bahadur, DM Pardhi, J Rautio, JM Rosenholm… - Pharmaceutics, 2020 - mdpi.com
The treatment of various central nervous system (CNS) diseases has been challenging,
despite the rapid development of several novel treatment approaches. The blood–brain …

Advances in Parkinson's disease: 200 years later

NLG Del Rey, A Quiroga-Varela, E Garbayo… - Frontiers in …, 2018 - frontiersin.org
When James Parkinson described the classical symptoms of the disease he could hardly
foresee the evolution of our understanding over the next two hundred years. Nowadays …

Increased risk of Parkinson disease with diabetes mellitus in a population-based study

YW Yang, TF Hsieh, CI Li, CS Liu, WY Lin, JH Chiang… - Medicine, 2017 - journals.lww.com
Increased risk of Parkinson disease with diabetes mellitus i... : Medicine Increased risk of
Parkinson disease with diabetes mellitus in a population-based study : Medicine Log in or …

Neuroimaging of Parkinson's disease: Expanding views

CP Weingarten, MH Sundman, P Hickey… - … & Biobehavioral Reviews, 2015 - Elsevier
Advances in molecular and structural and functional neuroimaging are rapidly expanding
the complexity of neurobiological understanding of Parkinson's disease (PD). This review …

Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage

I Paiva, R Pinho, MA Pavlou, M Hennion… - Human molecular …, 2017 - academic.oup.com
Alpha-synuclein (aSyn) is considered a major culprit in Parkinson's disease (PD)
pathophysiology. However, the precise molecular function of the protein remains elusive …

Therapies in Parkinson's disease

J Jankovic, W Poewe - Current opinion in neurology, 2012 - journals.lww.com
Numerous clinical trials have provided evidence that health-related quality of life can be
substantially improved with early diagnosis and institution of exercise and other physical …